drugset / Trial / NCT00627692
Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of constipation in elderly subjects living in a nursing facility. Hypothesis: Prucalopride up to a dose of 4 mg once daily is safe and well tolerated in in elderly subjects living in a nursing facility.
Timeline
- Start
- 1999-02
- Primary completion
- 2000-05
- Completion
- 2000-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 0.5 mg | Oral |
| Comparator | Prucalopride | Small molecule | 1 mg | Oral |
| Comparator | Prucalopride | Small molecule | 2 mg | Oral |
| Comparator | Prucalopride | Small molecule | 4 mg | Oral |